Clinical Trial Results:
A Phase IV Pilot Study to Evaluate Kidney Damage Measured by Neutrophil Gelatinase- Associated Lipocalin (NGAL) as a New Bio-Marker in Patients with Normal eGFR Undergoing Percutaneous Coronary Intervention with IOPAMIDOL Injection 370 or IODIXANOL 320
Summary
|
|
EudraCT number |
2010-019013-13 |
Trial protocol |
IT |
Global completion date |
11 Feb 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Oct 2016
|
First version publication date |
13 Oct 2016
|
Other versions |
|
Summary report(s) |
Study IOP-116 Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.